The COVID-19 pandemic significantly fast-tracked the advancement and adoption of digital health technologies, including AI and machine learning (ML), within the medical industry.

A prime example of this accelerated innovation is Otsuka’s digital health subsidiary, which has launched Rejoyn, its inaugural product. Rejoyn is a prescription-only app-based treatment designed to work alongside traditional medications for major depressive disorder. This innovative approach marks a significant step forward in digital therapeutics for mental health.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

GlobalData expects the digital health market to grow over the next decade and forecasts that its value will increase from $5.9 billion in 2023 at a compound annual rate of 13.1% to $15.4 billion by 2030.

Rejoyn, developed in collaboration with Click Therapeutics, utilises an emotion-recognition feature to engage neural pathways that are essential for emotional processing. This digital therapeutic received 510(k) clearance from the FDA in March 2024, reflecting its validated safety and efficacy. In a six-week trial, Rejoyn demonstrated a statistically significant improvement in depression severity, as measured by the Montgomery-Åsberg Depression Rating Scale.

Digital therapeutics can enhance patient care

The rapid expansion of the regulated mobile health app market reflects a broader trend toward digital health innovation. According to GlobalData, following a period of steady app growth from 2015 to 2019, the market experienced a dramatic surge of over 100% between 2019 and 2020. This surge highlights the accelerated adoption of mobile health solutions, driven by the need for advanced, accessible treatments.

The launch of Rejoyn, which integrates cognitive behavioural therapy into an app-based format, exemplifies this shift and emphasises the ongoing growth in app volume, which is projected to continue at a robust pace through 2033. This trend illustrates the increasing role of digital therapeutics in enhancing patient care and adapting to evolving healthcare needs.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.